IDYA
Published on 05/05/2026 at 07:35 am EDT
IDEAYA Biosciences, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported net loss was USD 98.54 million. Basic loss per share from continuing operations was USD 1.11.
Diluted loss per share from continuing operations was USD 1.11.